Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Pediatric Hematology
How would you approach management of bleeding risk and factor VIII replacement in a patient with severe hemophilia A undergoing stem cell transplant?
Answer from: at Academic Institution
Same way as anyone with severe hemophilia: Prophy with QOD factor or weekly hemlibra Extra correction for procedures, trauma, or bleeding
Comments
at Ann & Robert H. Lurie Children’s Hospital of Chicago
Thank you Dr. @Gary Kupfer! Would you have any con...
at Georgetown University Hospital
Good point. I wouldn’t say it is studied...
7770
7773
Sign in or Register to read more
15541
Related Questions
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Which classes of medications are reasonable to consider in cases of acute pericarditis in a patient with G6PD deficiency?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
What parameters would you use to monitor and interpret iron levels in a hemochromatosis patient where ferritin is unreliable due to underlying chronic inflammation?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Thank you Dr. @Gary Kupfer! Would you have any con...
Good point. I wouldn’t say it is studied...